BOSTON--(BUSINESS WIRE)--James K. Laird, CEO of BioPortUSA, announced today the launch of a commercialization accelerator that targets foreign life sciences companies wishing to establish a business presence in the U.S. market. BioPortUSA offers these companies access to U.S. market industry experts that first, undertake a comprehensive assessment of their readiness to enter the U.S. market; second, develop a highly customized commercialization plan; and third, implement some or all of the plan recommendations to assure efficient and effective market entry.
